Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Prior Stephen David
Chief Strategy Officer at AN2 Therapeutics. Filing since 3 Jan 2025.
CIK 0002042268
Company
Date
Role
Action
Shares
Amount
Of holding
ANTX
AN2 Therapeutics, Inc.
6 Jan 2026
Chief Strategy Officer
Sold at will
2,858
$2.89K
4.6%
ANTX
AN2 Therapeutics, Inc.
5 Jan 2026
Chief Strategy Officer
Sold at will
3,604
$3.61K
5.5%
ANTX
AN2 Therapeutics, Inc.
4 Nov 2025
Chief Strategy Officer
Sold at will
765
$872.10
1.2%
ANTX
AN2 Therapeutics, Inc.
3 Jan 2025
Chief Strategy Officer
Sold at will
2,029
$2.72K
5.7%
4 decisions on file.
